Eyal Breitbart

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index564citations59works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(18), Cancer Research and Treatments(15), Angiogenesis and VEGF in Cancer(7), Glioma Diagnosis and Treatment(6), RNA Interference and Gene Delivery(6)

Publications59 total

Data from Systemic Administration of a Conditionally Replicating Adenovirus, Targeted to Angiogenesis, Reduced Lung Metastases Burden in Cotton Rats
2023Open Access
Supplementary Figure S1 from Systemic Administration of a Conditionally Replicating Adenovirus, Targeted to Angiogenesis, Reduced Lung Metastases Burden in Cotton Rats
2023Open Access
Supplementary Figure S1 from Systemic Administration of a Conditionally Replicating Adenovirus, Targeted to Angiogenesis, Reduced Lung Metastases Burden in Cotton Rats
2023Open Access
Data from Systemic Administration of a Conditionally Replicating Adenovirus, Targeted to Angiogenesis, Reduced Lung Metastases Burden in Cotton Rats
2023Open Access
MOSPD2 regulates the activation state of αLβ2 integrin to control monocyte migration
The Journal of Immunology·2022
Abstract LB-086: CD3 MOSPD2 bi specific antibody significantly prolongs survival in a model of metastatic human cervical cancer without any evidence of toxicity
Cancer Research·2020
Abstract 5592: MOSPD2 a novel target for bi-specific antibody mediated solid tumor cells immune death
Cancer Research·2020
Motile sperm domain-containing protein 2: a novel therapeutic target for the treatment of non-alcoholic steatohepatitis
Journal of Hepatology·2020
FRI0007 MOSPD2: A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Annals of the Rheumatic Diseases·2020Open Access
Tu1663 MOSPD2: A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF INFLAMMATORY DIGESTIVE DISORDERS
Gastroenterology·2020
MOSPD2 is a therapeutic target for the treatment of CNS inflammation
Clinical & Experimental Immunology·2020· 12 citedOpen Access
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study
Neuro-Oncology·2019· 37 citedOpen Access
Abstract 4979: Ofranergene Obadenovec (VB-111), an anti-cancer gene therapy, induces immunologic responses in solid tumors transforming cold tumors to hot tumors
Cancer Research·2019· 2 cited
Abstract 4979: Ofranergene Obadenovec (VB-111), an anti-cancer gene therapy, induces immunologic responses in solid tumors transforming cold tumors to hot tumors
Immunology·2019· 3 cited
Treatment with lecinoxoids attenuates focal and segmental glomerulosclerosis development in nephrectomized rats
Basic & Clinical Pharmacology & Toxicology·2018· 7 citedOpen Access
Newly characterized motile sperm domain‐containing protein 2 promotes human breast cancer metastasis
International Journal of Cancer·2018· 8 citedOpen Access
Abstract LB-132: MOSPD2: A novel target for Bi-specific Ab mediated killing of tumor cells
Cancer Research·2018
ATIM-03. BIOMARKER ANALYSIS SUPPORTS THE VB-111 DUAL MECHANISM OF ACTION
Neuro-Oncology·2017Open Access
Abstract 4892: MOSPD2, a newly characterized protein, promotes breast cancer metastasis
Cancer Research·2017
Identification of Motile Sperm Domain–Containing Protein 2 as Regulator of Human Monocyte Migration
The Journal of Immunology·2017· 14 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Livnat Bangio(21), Dror Harats(21), Itzhak Mendel(20), Yaël C. Cohen(14), Niva Yacov(14), Aviv Shaish(11), Iris Barshack(11), Shoshana Greenberger(10), Andrew Brenner(9), Oshrat Propheta‐Meiran(9), Reshef Tal(9), Yaniv Salem(8), Nira Varda‐Bloom(7), Israel Hodish(6), Eti Ishai(6), Michael Peled(6), Katherine B. Peters(5), N. Sher(5), Niva Yakov(5), Patrick Y. Wen(5)